Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Augment Altern Commun ; 27(2): 67-76, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21592002

ABSTRACT

This study examined how infants' age, joint attention (JA) skills, caregiver ratings of language and temperament, and caregiver JA style related to JA in a structured literacy task with an augmentative and alternative communication (AAC) system. Sixteen infants (mean = 10.6 months) without disabilities participated in two storybook reading interactions with an experimenter in two conditions where the AAC system was either aligned or divided from the experimenter's eye gaze. Individual differences in JA skills, caregiver JA style, and temperament were associated with coordinated JA across both conditions. The findings suggest it is important to examine both extrinsic and intrinsic factors, which may not only reduce attention demands but also mediate the success of JA interactions with AAC systems.


Subject(s)
Attention , Communication Aids for Disabled , Language Development , Parent-Child Relations , Social Environment , Age Factors , Female , Fixation, Ocular , Humans , Individuality , Infant , Male , Professional-Patient Relations , Reading , Surveys and Questionnaires , Temperament
2.
J Neurovirol ; 12(4): 251-61, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16966216

ABSTRACT

Theiler's murine encephalomyelitis virus induces a demyelinating disease (TMEV-IDD) of the central nervous system (CNS) in susceptible mouse strains with accompanying histopathology characterized by mononuclear cell infiltrates. In susceptible strains of mice such as SJL, virus establishes a persistent infection in macrophages, induces a CNS infiltration by macrophages, T cells, and B cells, which results in chronic-progressive paralysis. In the present report the authors have investigated the functional role of CCL2 (monocyte chemotactic protein-1) in the induction and progression of demyelinating disease. Treatment of infected mice at day 0, 14, or 28 with anti-CCL2 resulted in a significant decrease in the clinical disease progression. Further analysis of anti-CCL2-treated mice revealed decreased CNS inflammation and mononuclear cell infiltration with an accompanying change in inflammatory cytokine responses. There was an overall decrease in the absolute numbers of CNS-infiltrating CD4+ T cells, macrophages, and B cells. Finally, anti-CCL2 treatment resulted in decreased viral load in the CNS. These data directly demonstrate a role for CCL2 in the pathogenesis of TMEV-IDD.


Subject(s)
Antibodies, Monoclonal/pharmacology , Cardiovirus Infections/therapy , Chemokine CCL2/antagonists & inhibitors , Demyelinating Diseases/therapy , Theilovirus/growth & development , Animals , Antibodies, Monoclonal/immunology , Cardiovirus Infections/immunology , Central Nervous System/immunology , Central Nervous System/pathology , Chemokine CCL2/immunology , Demyelinating Diseases/immunology , Demyelinating Diseases/virology , Female , Inflammation/immunology , Inflammation/pathology , Inflammation/virology , Leukocytes, Mononuclear/immunology , Mice , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL